News - MedTech & Diagnostics
Game-changing portable CT scanner to allow rapid access to treatment

MedTech News: Innovative Adelaide-based manufacturer has received funding to develop a game-changing portable brain scanner from the Australian Government’s Medical Research Future Fund (MRFF).
The scanner will be small enough to be placed in ambulances or Royal Flying Doctor Service aircraft and will give more Australians rapid access to treatment in the crucial first “golden hour” after a stroke.
It is expected to revolutionise stroke care particularly for rural and remote Australians who are twice as likely as city stroke survivors to be left with a serious, lifelong disability.
The Australian Stroke Alliance received $40 million under the initiative for a five-year program to lay the foundations for a national and equitable approach to the treatment of stroke.
Micro-X will receive $8 million of that to develop the portable scanner using their unique technology.
Stroke patients have a much greater chance of surviving and avoiding long-term brain damage if they are diagnosed and treatment begins within that first hour.
“We are excited to be at the forefront in developing technology which has the potential to radically transform health care for all Australians,” Micro-X Managing Director Peter Rowland said.
“This unique collaboration puts Australia and the Australian Stroke Alliance at the forefront of global best practice in stroke care which may be adopted as the new standard for stroke diagnosis.”
The Frontier Health and Medical Research Initiative allows researcher collaborations to explore bold and exciting ideas that could have a dramatic, global impact on health care.
Micro-X, based in the Tonsley innovation hub in southern Adelaide, has developed world-leading, proprietary technology for miniaturising x-ray sources.
The breakthrough was made possible by the discovery of Micro-X’s patented carbon nanotube (CNT) emitter technology.
Human Resources
Merck puts the ‘family’ in workplace as fertility survey exposes gaps
Merck has announced the results of its Fertility Futures Survey of 1,500 Australians aged 18 to 35, revealing significant gaps […]
MoreNews - MedTech & Diagnostics
Australia has a new genomics framework. But will patients see the difference?
The government has released the National Health Genomics Policy Framework and Implementation Plan 2026–2030, jointly developed by the federal and […]
MoreNews - Pharmaceuticals
PCFA condemns funding axe and demands Prime Minister intervene
The Prostate Cancer Foundation of Australia (PCFA) has condemned the Albanese Government’s decision to end funding for its national Prostate […]
MoreNews - Pharmaceuticals
Sanofi’s clinical-trial push hits a GP reality check
New research from Sanofi presented at the Australian Public Health Conference this week points to an addressable opportunity to increase […]
More